全球微流體市場規模、佔有率、成長分析，依技術（醫療和非醫療）、依材料（矽、玻璃）分類 - 產業預測 2024-2031

Global Microfluidics Market Size, Share, Growth Analysis, By Technology(Medical and Non- Medical), By Material(Silicon, Glass) - Industry Forecast 2024-2031

出版日期: 2024年04月07日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年全球微流控市場規模為206.3億美元，預計將從2023年的232.5億美元成長到2031年的582.3億美元，在預測期內（2024-2031年）複合年成長率為12.22%。

與傳統流體測量工具相比，微流體技術需要更少的樣品和更小的儀器，提供增強的參數控制和資料質量，使其成為 PCR 擴增、細胞分離和 DNA 分析的普遍選擇。《PLOS One》上發表的一項研究預測，到2025 年，法國將有約280 萬例慢性阻塞性肺病(COPD) 病例，透過使用微流控晶片和最少的血液樣本進行COPD 檢測的需求增加，將推動市場成長。澳洲的失智症發生率預計將從2022 年的487,500 例上升到2058 年的110 萬例，因此越來越需要有效的藥物發現、篩選方法和毒理學研究，從而推動了對能夠促進骨骼、神經膠質細胞研究的微流體系統的需求。總體而言，微流體設備在不同研究和診斷領域的廣泛使用預計將推動市場成長。

市場概況
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 歐洲其他地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 拉丁美洲其他地區
中東和非洲 (MEA)
- 海灣合作理事會國家
- 南非
- MEA 的其餘部分

競爭格局

前 5 名企業比較
2021 年關鍵參與者的市場定位
主要市場參與者所採取的策略
最佳制勝策略
近期市集活動
主要公司市佔率（%），2021年

主要公司簡介

Danaher Corporation (US)
Thermo Fisher Scientific Inc. (US)
Agilent Technologies, Inc. (US)
PerkinElmer, Inc. (US)
Bio-Rad Laboratories, Inc. (US)
Dolomite Microfluidics (UK)
Micronit Microfluidics BV (Netherlands)
Fluidigm Corporation (US)
Sphere Fluidics Ltd. (UK)
Fluigent (France)
Elveflow (France)
Cellix Ltd. (Ireland)
MicroLIQUID SL (Spain)
Abbott Laboratories (US)
Roche Diagnostics (Switzerland)
uFluidix (Canada)
microfluidic ChipShop GmbH (Germany)
Micralyne Inc. (Canada)
microLIQUID (Spain)
MicruX Technologies (Spain)
MiniFAB Pty Ltd. (Australia)
Micromotive GmbH (Germany)

簡介目錄

Product Code: SQMIG35A2288

Global Microfluidics Market size was valued at USD 20.63 billion in 2022 and is poised to grow from USD 23.25 billion in 2023 to USD 58.23 billion by 2031, growing at a CAGR of 12.22% during the forecast period (2024-2031).

Microfluidic technology, requiring fewer samples and smaller instruments compared to traditional fluid measurement tools, offers enhanced parameter control and data quality, making it a prevalent choice in PCR amplification, cell separation, and DNA analysis. A study published in PLOS One forecasts approximately 2.8 million cases of chronic obstructive pulmonary disease (COPD) in France by 2025, driving market growth through increased demand for COPD testing using microfluidic chips and minimal blood samples. With dementia rates in Australia expected to escalate from 487,500 cases in 2022 to 1.1 million by 2058, there is a rising necessity for efficient medication discovery, screening methods, and toxicological investigations, propelling the demand for microfluidic systems capable of facilitating research on skeletal, glial, and endothelial cells to explore organogenesis and disease etiology while ensuring fluid isolation of muscle cells. Overall, the expanding utilization of microfluidic devices across diverse research and diagnostic domains is anticipated to fuel market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Microfluidics Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Microfluidics Market Segmental Analysis

Global Microfluidics Market is segmented on the basis of technology, material, application type and region. By technology, the market is segmented into medical and non-medical. By material, market is segmented into silicon, glass, polymer, PDMS, others. By application, the marker is segmented into lab-on-a-chip, organs-on-chip, continuous flow microfluidics, optofluidic & microfluidics, acoustofluidics & microfluidics, electrophoresis & microfluidics. By type, the market is segmented into microfluidics chips, microfluidics sensors, microfluidics pumps, others. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Microfluidics Market

The rising adoption of microfluidic devices in personalized medicine stems from their capacity to deliver both high-throughput and high-quality outcomes. As the demand for personalized medical solutions continues to surge, there is an anticipation of substantial growth in the microfluidic device market to meet these evolving needs.

Restraints in the Global Microfluidics Market

The intricacies of manufacturing microfluidic devices demand precision and expertise, posing challenges for companies aiming to expand production and reduce expenses due to the complexity involved in the process.

Market Trends of the Global Microfluidics Market

Point-of-care testing (POCT) involves medical diagnostic procedures conducted outside traditional clinical laboratory settings, such as in a doctor's office, hospital ward, or home environment, aiming for greater convenience and rapid results. The rising popularity of POCT is driving demand for microfluidic devices, which are particularly suitable for such testing scenarios, owing to their agility and efficiency.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Microfluidics Market by Technology

Market Overview
Medical and Non- Medical

Global Microfluidics Market by Material

Market Overview
Silicon
Glass
Polymer
PDMS
Others

Global Microfluidics Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

Danaher Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PerkinElmer, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Dolomite Microfluidics (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Micronit Microfluidics BV (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fluidigm Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sphere Fluidics Ltd. (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fluigent (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Elveflow (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cellix Ltd. (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MicroLIQUID SL (Spain)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Roche Diagnostics (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
uFluidix (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
microfluidic ChipShop GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Micralyne Inc. (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
microLIQUID (Spain)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MicruX Technologies (Spain)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MiniFAB Pty Ltd. (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Micromotive GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments